Literature DB >> 14624057

Methylenedioxymethamphetamine (MDMA, 'ecstasy') serves as a robust positive reinforcer in a rat runway procedure.

Gudrun Wakonigg1, Katja Sturm, Alois Saria, Gerald Zernig.   

Abstract

Although 'ecstasy' (3,4-methylenedioxymethamphetamine, MDMA) is, after marijuana, the second most prevalent illegal drug of abuse in European adolescents, animal experimental evidence of MDMA's reinforcing effect has remained scarce, particularly in the rodent model, raising questions about the robustness of MDMA's reinforcing effect under controlled laboratory conditions. In the present rat runway study, Sprague-Dawley and Long-Evans rats were given the opportunity to run for intravenous injections of saline or MDMA (1 mg/kg). MDMA significantly decreased runtimes in both rat strains. Thus, MDMA's positive reinforcing effect can be demonstrated not only across rat strains but also across operant conditioning paradigms. These findings should reassure the drug abuse research community that the investigation of MDMA's reinforcing effect in the inexpensive and widely used rodent model is indeed feasible. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14624057     DOI: 10.1159/000073661

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  9 in total

1.  Reinstatement of MDMA (ecstasy) seeking by exposure to discrete drug-conditioned cues.

Authors:  Kevin T Ball; Kelly M Walsh; George V Rebec
Journal:  Pharmacol Biochem Behav       Date:  2007-06-02       Impact factor: 3.533

2.  Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats.

Authors:  Kevin T Ball; George V Rebec
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

3.  Simultaneous intra-accumbens remifentanil and dopamine kinetics suggest that neither determines within-session operant responding.

Authors:  Jose A Crespo; Katja Sturm; Alois Saria; Gerald Zernig
Journal:  Psychopharmacology (Berl)       Date:  2005-11-09       Impact factor: 4.530

Review 4.  3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings.

Authors:  Michael H Baumann; Xiaoying Wang; Richard B Rothman
Journal:  Psychopharmacology (Berl)       Date:  2006-03-16       Impact factor: 4.530

Review 5.  Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.

Authors:  João Paulo Capela; Helena Carmo; Fernando Remião; Maria Lourdes Bastos; Andreas Meisel; Félix Carvalho
Journal:  Mol Neurobiol       Date:  2009-04-17       Impact factor: 5.590

6.  Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA).

Authors:  Michael H Baumann; Richard B Rothman
Journal:  Int Rev Neurobiol       Date:  2009       Impact factor: 3.230

Review 7.  The runway model of drug self-administration.

Authors:  Aaron Ettenberg
Journal:  Pharmacol Biochem Behav       Date:  2008-11-13       Impact factor: 3.533

Review 8.  Relevance of rodent models of intravenous MDMA self-administration to human MDMA consumption patterns.

Authors:  R De La Garza; K R Fabrizio; A Gupta
Journal:  Psychopharmacology (Berl)       Date:  2006-02-10       Impact factor: 4.530

9.  Activation of PKCzeta and PKMzeta in the nucleus accumbens core is necessary for the retrieval, consolidation and reconsolidation of drug memory.

Authors:  Jose A Crespo; Petra Stöckl; Florian Ueberall; Marcel Jenny; Alois Saria; Gerald Zernig
Journal:  PLoS One       Date:  2012-02-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.